Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Molho-Sabatier

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
La Revue De Medecine Interne|September 1, 1987
[The endothelium and thrombosis]P Molho-Sabatier
La Revue De Medecine Interne|January 1, 1991
[Darkness and light on blood coagulation abnormalities associated with thrombo-embolic venous disease]P Molho-Sabatier
La Revue Du Praticien|November 10, 1988
[Anomalies of hemostasis and venous thromboses]M Aiach, P Molho-Sabatier, P Priollet
Presse Medicale (Paris, France : 1983)|October 12, 1991
[Kaposi's sarcoma in multiple myeloma]E Pertuiset, P Molho-Sabatier, F Liote, et al.
British Journal of Haematology|June 1, 1990
Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutationN de Roux, G Chadeuf, P Molho-Sabatier, et al.
The New England Journal of Medicine|March 7, 1996
Autoantibodies against erythropoietin in a patient with pure red-cell aplasiaN Casadevall, E Dupuy, P Molho-Sabatier, et al.
Thrombosis and Haemostasis|February 19, 1990
A plasma clot lysis assay based on the release of fibrin degradation products: application to the diagnosis of hypofibrinolytic statesP Gaussem, S Gandrille, P Molho-Sabatier, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
Genetic diagnosis of qualitative and quantitative antithrombin III deficienciesE Clauser, S Gandrille, D Vidaud, et al.
Thrombosis and Haemostasis|November 1, 1994
Ex vivo inhibition of platelet aggregation in patients with severe limb arteriopathy treated with BAY U3405, a specific TX A2 receptor antagonistS Bellucci, W Kedra, H Groussin, et al.
Thrombosis and Haemostasis|April 12, 1990
Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiencyM Wolf, C Boyer-Neumann, P Molho-Sabatier, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
La Revue De Medecine Interne|September 1, 1987
[The endothelium and thrombosis]P Molho-Sabatier
La Revue De Medecine Interne|January 1, 1991
[Darkness and light on blood coagulation abnormalities associated with thrombo-embolic venous disease]P Molho-Sabatier
La Revue Du Praticien|November 10, 1988
[Anomalies of hemostasis and venous thromboses]M Aiach, P Molho-Sabatier, P Priollet
Presse Medicale (Paris, France : 1983)|October 12, 1991
[Kaposi's sarcoma in multiple myeloma]E Pertuiset, P Molho-Sabatier, F Liote, et al.
British Journal of Haematology|June 1, 1990
Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutationN de Roux, G Chadeuf, P Molho-Sabatier, et al.
The New England Journal of Medicine|March 7, 1996
Autoantibodies against erythropoietin in a patient with pure red-cell aplasiaN Casadevall, E Dupuy, P Molho-Sabatier, et al.
Thrombosis and Haemostasis|February 19, 1990
A plasma clot lysis assay based on the release of fibrin degradation products: application to the diagnosis of hypofibrinolytic statesP Gaussem, S Gandrille, P Molho-Sabatier, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
Genetic diagnosis of qualitative and quantitative antithrombin III deficienciesE Clauser, S Gandrille, D Vidaud, et al.
Thrombosis and Haemostasis|November 1, 1994
Ex vivo inhibition of platelet aggregation in patients with severe limb arteriopathy treated with BAY U3405, a specific TX A2 receptor antagonistS Bellucci, W Kedra, H Groussin, et al.
Thrombosis and Haemostasis|April 12, 1990
Familial variant of antithrombin III (AT III Bligny, 47Arg to His) associated with protein C deficiencyM Wolf, C Boyer-Neumann, P Molho-Sabatier, et al.
Pageof 2